Nazione: Svizzera
Lingua: francese
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
doxorubicini hydrochloridum
Accord Healthcare AG
L01DB01
doxorubicini hydrochloridum
Solution injectable
doxorubicini hydrochloridum 20 mg, natrii chloridum corresp. natrium 35.4 mg, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 10 ml.
A
Synthetika
Cytostatique
zugelassen
2022-07-14